This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
Revised International Staging System for MM (2014)
HRCA, high-risk cytogenetic abnormalities; LDH, lactate dehydrogenase; MG, microglobulin; MM, multiple myeloma; OS, overall survival.
Palumbo, et al. J Clin Oncol. 2015;33(26):2863-2869.
Would you like to clear and leave your conversation? Message history will be lost.